1-1 of 1
Pedro Mejia, PhD
Close
Sort by
Journal Articles

Senicapoc, a Gardos Channel Inhibitor Developed to Treat Sickle Cell Disease, Exhibits Antimalarial Activity

Venee N. Tubman, MD MMSc, Pedro Mejia, PhD, Boris E. Shmukler, PhD, Seth L. Alper, MD PhD, James R. Mitchell, PhD, Carlo Brugnara, MD, Manoj T. Duraisingh, PhD
Journal: Blood
Blood (2014) 124 (21): 743.
https://doi.org/10.1182/blood.V124.21.743.743
Published: 2014